大会报告撷萃
未来合作
影响与意义
J MED's Participation in ESSO Annual Congress, Antwerp 2024
Event Overview
From October 2nd to 4th, 2024, J-Med (Jiahui Medical Research and Education), a prominent medical publication and platform for healthcare advancements, joined forces with the European Society of Surgical Oncology (ESSO) as a partner for their annual congress held in Antwerp, Belgium.
This prestigious gathering attracted an impressive audience of 1011 participants from 76 countries, showcasing the global reach and importance of surgical oncology in contemporary medicine.
Scientific Presentations
The congress featured a robust scientific program that highlighted the latest research and developments in surgical oncology.
Notably, three esteemed professors from China's leading medical institutions made significant contributions to the proceedings. Professor Xinxiang Li, representing Shanghai Cancer Hospital of Fudan University, presented groundbreaking work on the treatment of rectal cancer, underscoring the latest advancements in organ preservation and challenges in this field. Similarly, Professor Yingbin Liu from Renji Hospital of Shanghai Jiaotong University shared insights into biliary cancer research and clinical development while Professor Jun Li from Shanghai Jiahui International Hospital discussed the recent progress in liver cancer treatment by robotic assistant surgery.
These presentations not only showcased China's medical prowess but also fostered international collaboration and knowledge exchange.
Future Collaborations
A highlight of J-Med's participation was the discussion held between Dr. Paula Li, the Director of J-Med, and a select group of medical experts, including Professor Jun Li (Chief of Surgery and Surgical Oncology at Jiahui International Hospital) and Professor Tibor Kovacs (Honorary Chief of Breast Institute in Jiahui International Hospital).
This dialogue focused on potential future collaborations with ESSO's core team, particularly in the areas of breast cancer, colorectal cancer, and hepatopancreaticobiliary cancer treatment. The discussions emphasized the importance of combining international expertise and resources to improve patient outcomes and advance the field of surgical oncology.
Impact and Significance
J-Med's active participation in the ESSO annual congress underscores its commitment to promoting global healthcare excellence and facilitating international cooperation. By bringing together leading experts from around the world, the congress provided a platform for sharing best practices, discussing challenges, and identifying new avenues for research and treatment. The discussions on future collaborations hold promise for accelerating medical advancements and enhancing patient care, particularly in the complex and rapidly evolving realm of surgical oncology.
In conclusion, the ESSO Annual Meeting in Antwerp served as a testament to the international community's dedication to advancing surgical oncology and improving the lives of patients worldwide. J-Med's role as a partner and contributor to this event highlights its ongoing efforts to bridge the gap between medical professionals and foster global innovation in healthcare.
版权信息
